SIMPLY inhaling a vaccine could protect women against cervical cancer. Preliminary tests show the vaccine can trigger an immune response similar to that seen with the injectable vaccine, soon to be approved in the US and Europe.
The aerosol spray consists of particles derived from the outside of human papilloma virus 16, one of four strains of the virus responsible for the majority of cervical cancer cases. When inhaled, it stimulates production of antibodies against the virus.
The spray needs two doses, spaced two weeks apart, compared to the injectable vaccine, which requires three doses over six months. Denise Nardelli-Haefliger…
